The Latin America, Middle East and Africa Artificial Intelligence in Diagnostics Market would witness market growth of 24.1% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Artificial Intelligence in Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $126.4 million by 2031. The Argentina market is showcasing a CAGR of 25% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 23% during (2024 - 2031).
AI is being utilized across various diagnostic fields, enhancing the speed and accuracy of disease detection and management. AI-powered imaging tools are revolutionizing radiology by improving image interpretation in X-rays, MRIs, CT scans, and ultrasounds. AI algorithms help detect abnormalities such as tumors, fractures, and cardiovascular diseases more accurately and efficiently. AI-powered radiology tools also reduce the workload on radiologists by automating routine image analysis and providing clinical decision support.
Moreover, AI assists in analyzing pathology slides with high precision, aiding in identifying diseases such as cancer. Digital pathology and AI enable remote diagnosis, facilitating access to expert opinions even in remote locations. AI models are trained to detect patterns in tissue samples, reducing diagnostic errors and speeding up the process. AI-driven diagnostic tools help detect cardiovascular diseases, assess heart conditions, and predict potential risks based on ECG readings and imaging studies.
In Brazil, AI spending surpassed $1 billion in 2023, reflecting a 33% year-over-year growth. The increase in Intelligent Process Automation (IPA) investments, which reached $214 million, signifies the country’s strong push toward digital transformation, including in the healthcare sector. AI-powered diagnostic solutions can benefit from this momentum, improving efficiency in medical imaging, disease detection, and patient monitoring. As AI continues to mature in Brazil, its application in diagnostics will enhance early disease detection, reduce diagnostic errors, and optimize clinical workflows, positioning AI-driven diagnostics as a critical part of the country’s healthcare evolution.
Free Valuable Insights: The Worldwide Artificial Intelligence in Diagnostics Market is Projected to reach USD 5.80 Billion by 2031, at a CAGR of 21.3%
Based on Component, the market is segmented into Software, Hardware, and Services. Based on Diagnosis, the market is segmented into Neurology, Radiology, Chest & Lung, Oncology, Cardiology, Pathology, and Other Diagnosis. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By Component
By Diagnosis
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 